TP53 and neoplasm: Our study provides further insights into this area, demonstrating that patients with squamous cell lung cancer, smoking history, or larger tumor sizes exhibit more ctDNA shedding, a finding that aligns with previous research.[12] Additionally, we identified adjuvant treatment, TP53 mutations, and genomic instability as other factors associated with increased ctDNA release.